A detailed history of Clearwater Capital Advisors, LLC transactions in Ishares Tr Genomics Immunology stock. As of the latest transaction made, Clearwater Capital Advisors, LLC holds 84,242 shares of IDNA stock, worth $1.87 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
84,242
Previous 55,158 52.73%
Holding current value
$1.87 Million
Previous $1.36 Million 40.46%
% of portfolio
0.2%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$22.38 - $25.53 $650,899 - $742,514
29,084 Added 52.73%
84,242 $1.91 Million
Q3 2024

Nov 12, 2024

BUY
$22.86 - $25.49 $8,458 - $9,431
370 Added 0.68%
55,158 $1.36 Million
Q2 2024

Aug 06, 2024

BUY
$21.71 - $24.69 $33,086 - $37,627
1,524 Added 2.86%
54,788 $1.27 Million
Q1 2024

May 09, 2024

SELL
$22.28 - $25.2 $7,352 - $8,316
-330 Reduced 0.62%
53,264 $1.28 Million
Q4 2023

Feb 06, 2024

BUY
$17.37 - $23.3 $930,927 - $1.25 Million
53,594 New
53,594 $1.23 Million

Others Institutions Holding IDNA

About ISHARES TR GENOMICS IMMUNOLOGY


  • Ticker IDNA
  • Sector ETFs
  • Industry ETFs
More about IDNA
Track This Portfolio

Track Clearwater Capital Advisors, LLC Portfolio

Follow Clearwater Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearwater Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearwater Capital Advisors, LLC with notifications on news.